Betta Pharmaceuticals Co., Ltd. engages in the research and development, production and sale of anticancer targeted drugs. Its product icotinib hydrochloride tablet, provides treatment for non-small cell lung carcinoma disease. The company was founded on January 7, 2003 and is headquartered in Hangzhou, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company